Beta adrenoceptors and regenerating corneal epithelium

Area of Science:

• Ophthalmology
• Pharmacology
• Cell Biology

Background:

• Beta blockers are known to inhibit corneal re-epithelialization.
• This effect may be mediated by beta-2 adrenergic receptor mechanisms.

Purpose of the Study:

• To investigate the differential effects of beta-1 and beta-2 blockers on corneal wound healing.
• To compare the efficacy of betaxolol hydrochloride (beta-1) and L132-468 (beta-2) in promoting corneal re-epithelialization.

Main Methods:

• A randomized, double-masked study was conducted on 60 rabbits with iatrogenically induced corneal ulcers.
• Rabbits were treated with betaxolol hydrochloride 0.25% (beta-1), L132-468 0.25% (beta-2), or phosphate-buffered solution (PBS) as a control.
• Wound healing rates were assessed at 24, 48, and 72 hours, with scanning electron microscopy (SEM) used on day 20.

Main Results:

• No significant difference in healing rates was observed at 24 hours.
• Significant differences in healing rates were noted at 48 hours (p < 0.01).
• At 72 hours, L132-468 (beta-2) treated corneas showed significantly less healing than betaxolol hydrochloride (beta-1) treated corneas. PBS group healed by 72 hours.
• SEM revealed complete healing with normal microvilli in betaxolol-treated corneas, while L132-468 treated corneas showed desquamation and abnormal cells.

Conclusions:

• Beta-2 blockers inhibit corneal re-epithelialization more potently than beta-1 blockers.
• The findings suggest a specific role for beta-2 adrenergic receptors in the corneal healing process.